The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Infliximab
Australian Public Assessment Report
Device/Product Name
Remicade
Active ingredients
Infliximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2011-00196-3-1
Submission Type
Extension of indications
Decision
Approved